Forty-two patients with mBrCa refractory to previous lines of treatment underwent surgical resection of a metastatic lesion(s), isolation of TIL cultures, identification of exomic nonsynonymous tumor ...

In a recent study published in Scientific Reports, researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and severe acute respiratory syndrome coronavirus 2 ...

An interesting new paper presents a new assay for B and T lymphocytes in individuals infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This B And T cell Tandem Lymphocyte ...

Scientists at the National Cancer Institute (NCI) report that in a clinical trial of 42 women with metastatic breast cancer, 28 (or 67 percent) generated an immune reaction against their cancer. The ...

Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide ...

Please provide your email address to receive an email when new articles are posted on . At baseline, patients with JIA had higher C-reactive protein and CRP-to-albumin ratio vs. controls. C-reactive ...

Autoantibodies are antibodies that target the body’s own antigens. These antigens may consist of proteins, nucleic acids, carbohydrates, or lipids expressed ubiquitously throughout the body or only in ...

Vaccination efforts worldwide have drastically diminished morbidity and mortality rates for many infectious diseases, with some pathogens being entirely eradicated. However, to optimize long-term ...

Metastatic breast cancer (mBrCa) is most often an incurable disease with only modest responses to available immunotherapies. This study investigates the immunogenicity of somatic mutations in breast ...